Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available in the years 2014 to 2020 – in addition to the private investment it will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
Thanks to the Marie Skłodowska-Curie Actions (MSCA), Small and Medium-sized enterprises can now collaborate with academic research organisations, have access to their facilities and integrate some of their highly skilled researchers within the research projects of the company.
Being a RISE project, VACCINESURVEY is based on a number of scientific objectives and deliverables implemented through international and intersectoral staff exchange (secondments), thus maximising the impact of the action for knowledge sharing, skills development and long-term research collaboration.